IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
Content includes: - Market Data - Interviews and Analysis - Special Features (Market Forecasts, M&A Analysis, Executive Compensation Table, Surveys, etc.) - Company Financial Results - Product Developments - Regional and Industry Opportunities
Page Count: 50
Table of Contents
COVID-19 Negatively Impacts IBO Sales Indexes
End-Markets
Regions
Product Lines
Quarterly and Full-Year Forecasts
Berkeley Lights Discusses the Company Post-IPO
COVID-19 and Reduced Spending Mark Changes at Lab Testing Firms ALS and Eurofins
Eurofins
ALS
Executive Briefing
US Court Stays BGI Genomics’ Injunction
CELLINK Expands Single-Cell and Low-volume Dispensing Technology
VERDER Scientific Grows Particle Characterization Business
Bionano Genomics Directly Enters LDT Service Market
IBO Stock Indexes Continue to Rise as US Economy Exhibits Long-Term Optimism
Laboratory Instruments and Products Stock Index
Diversified Instrumentation Stock Index
International Stocks
Second Quarter Results: Agilent Technologies, Bio-Rad Laboratories, Bruker, MilliporeSigma and QIAGEN
Agilent Technologies’ Sales in China Experience an Uptick Amidst COVID-19 Challenges
Bio-Rad Revenues Fall Despite Strong PCR Sales
Bruker Second Quarter Sales Fall Amidst COVID-19 Pandemic
Q2 & H1
COVID-19 Disruptions Negatively Impact MilliporeSigma’s Second Quarter Revenues
QIAGEN Experiences Significant Revenue Gains for the Life Science Division
What is the Size of IVD Market Segments? Who’s Winning? Who’s Merged? Who’s Launched Game-Changing Products?
One book definitively answers these questions, from a publisher that is focused on in vitro diagnostics. Now in its 13th edition, this…